miércoles, 2 de diciembre de 2015

原発性リンパ浮腫と二次性リンパ浮腫 欧州連合(EU)の推定有病率 。リンパ水腫。疫学。有病率。発生率。影響を受けた人の推定数。推定人口。リンパ系の病気によって影響を受ける欧州連合の 1900 万人を推。欧州連合加盟国が記載されています。 ПЕРВИЧНАЯ ЛИМФЕДЕМА И ВТОРИЧНОЙ ЛИМФЕДЕМЫРАСЧЕТНАЯ РАСПРОСТРАНЕННОСТЬ В ЕВРОПЕЙСКОМ СОЮЗЕ / ЭПИДЕМИОЛОГИЯ / ПОКАЗАТЕЛЬ РАСПРОСТРАНЕННОСТИ / РАСЧЕТНОЕ КОЛИЧЕСТВО ЛЮДЕЙ, СТРАДАЮЩИХ / ОЦЕНКА БРЕМЕНИ НАСЕЛЕНИЯ / ПО ОЦЕНКАМ, 19 МИЛЛИОНОВ ЧЕЛОВЕК В СТРАНАХ ЕВРОПЕЙСКОГО СОЮЗА, ПОСТРАДАВШИХ ОТ ЗАБОЛЕВАНИЙ ЛИМФАТИЧЕСКОЙ СИСТЕМЫ / СПИСОК СТРАН — ЧЛЕНОВ ЕВРОПЕЙСКОГО СОЮЗА / 原發性淋巴水腫和繼發性淋巴水腫在歐洲聯盟估計流行。流行病學。發生率。受影響的人估計數。估計人口負擔。估計有十九萬人在歐盟影響的疾病的淋巴系統。列出由歐洲聯盟成員國。


ESTIMATED POPULATION AFFECTED BY DISEASES OF THE LYMPHATIC SYSTEM IN THE EUROPEAN UNION LISTED BY COUNTIES






ESTIMATED  NUMBER OF PEOPLE AFFECTED IN
THE EUROPEAN UNION


COUNTRY 
EPIDEMIOLOGY


3.099.460
2.424.048
2.380.846
2.290.133
SPAIN
1.764.990
POLAND
1.433.270
ROMANIA
811.506
NETHERLANDS
630.092
BELGIUM
417.916
GREECE
417.315
CZECH REPUBLIC
402.768
PORTUGAL
397.886
HUNGARY
372.494
SWEDEN
361.172
AUSTRIA
319.741
BULGARIA
268.800
DENMARK
211.507
SLOVAKIA
204.531
FINLAND
204.131
IRELAND
175.400
CROATIA
160.202
LITHUANIA
112.811
SLOVENIA
77.835
LATVIA
76.542
ESTONIA
48.141
CYPRUS
43.240
LUXEMBOURG
20.129
MALTA
16.130







Referencias & Información:

1/   Schingale, Franz-Josef, "Lymphoedema, Lipoedema, Diagnosis and Therapy: A Guide for Those  Affected,"  2003, Hannover: Schlütersche  GmbH & Co. KG.
2/   Macdonald, J., Geyer, M. (2010) Wounds and Lymphoedema Management. Geneva: WHO (World Health  Organization).
3/    Földi M, Földi E, Strössenreuther RHK & Kubik S. Földi’s textbook of lymphology: for physicians and lymphedema therapists. München, Germany: Elsevier, Urban & Fischer Verlag, 2012.


IMPORTANT NOTICE 

Lymphedema is a serious chronic and progressive disease due to an organic disability. The clinical treatment of lymphedema is neither a cosmetic nor an aesthetic treatment. The treatment of lymphedema is to control its progression and alleviate the symptoms related to dysfunction of the lymphatic circulatory system. To prevent and avoid serious complications associated with treatment, such as the possible displacement of edema to previously unaffected areas when compression therapy is applied for volume reduction, patients should use highly specialized and experienced therapists. 

Professional qualification and instruction delivered remotely online are not the same as live hands-on practical instruction in the clinical training and certification of lymphedema therapists, similar to all other rehabilitation, medical, and surgical training programs, and especially for developing the necessary manual skills to treat a disease as complex as lymphedema. 

Patients should also take special care when choosing a "Multidisciplinary Center of Reference for Lymphedema", as not all countries and centers provide the same treatment options. The best choice is a center of reference that provides “Complete Decongestive Therapy (CDT)”, which is recognized as the “Gold Standard” treatment for lymphedema.

  • Read more about what is the best treatment option for Lymphedema HERE.
  • Read about what are the principal functions of Manual Lymphatic Drainage HERE.
  • Read about what are the main differences between the two principal lymphedema treatment protocols HERE. 
  • Read about what are the strategies for the implementation of low-cost treatment options for Lymphedema HERE.

REFERENCES

(Click on the texts to read the research articles)

SCIENTIFIC SOCIETIES

PATHOPHYSIOLOGY

CUTANEOUS COMPLICATIONS
INFECTIOUS COMPLICATIONS
CELLULITIS / DERMATOLYMPHANGIOADENITIS
TUMOURS

TREATMENT

COMPRESSION GARMENTS

DISABILITY

DISFIGUREMENT

PSYCHOSOCIAL IMPACT

PEDIATRIC LYMPHEDEMA

LYMPHATIC FILARIASIS / PODOCONIOSIS



Articles that may also interest you: 
(Click on the texts)

    WHAT KIND OF DOCTOR TREATS LYMPHEDEMA/LYMPHOEDEMA - WHICH MEDICAL SPECIALITIES ARE RELATED TO LYMPHEDEMA?








































CLICK ON THE TEXTS
FOR LYMPHEDEMA INCIDENCE
AND PREVALENCE








Print this post